ABBV vs UHS · P/E 81, rev $16.99B vs P/E 5.9, rev $9.13B
AbbVie Inc (ABBV) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported UHS revenue for 2026-06-30 was $9.13B. Net income was $707.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the ABBV and UHS stock pages for the full models.
Not investment advice.